PDF herunterladen
Semin intervent Radiol 2012; 29(01): 052-056
DOI: 10.1055/s-0032-1302452
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Aggressive Management of Pulmonary Embolism

Nael Saad
1   Department of Radiology & Surgery, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
16. April 2012 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Pulmonary embolism (PE) and deep vein thrombosis are two elements of the same pathophysiological process referred to as venous thromboembolism. PE occurs when a thrombus migrates from a deep vein to the pulmonary arteries. Although the true incidence of PE is not known, it is estimated that 530,000 cases of PE occur annually in the United States. Clinical presentation varies from asymptomatic (incidentally diagnosed) to fatal. Development of symptoms depends on the embolic burden and the severity of any underlying cardiopulmonary disease. Several treatment options are available for patients diagnosed with PE. The mainstay of treatment is anticoagulation, but given the high mortality associated with some presentations of symptomatic PE, some advocate more aggressive therapy. In this article we discuss such therapies and their potential and appropriate use.

Keywords

pulmonary embolism - thrombolysis - catheter-directed thrombolysis - pharmaco-mechanical thrombolysis
 

  • References

  • 1 Key NS, Kasthuri RS. Current treatment of venous thromboembolism. Arterioscler Thromb Vasc Biol 2010; 30 (3) 372-375
    CrossrefPubMedSuche in Google Scholar
  • 2 Banovac F, Buckley DC, Kuo WT , et al; Technology Assessment Committee of the Society of Interventional Radiology. Reporting standards for endovascular treatment of pulmonary embolism. J Vasc Interv Radiol 2010; 21 (1) 44-53
    CrossrefPubMedSuche in Google Scholar
  • 3 Kuo WT, Sze DY, Hofmann LV. Catheter-directed intervention for acute pulmonary embolism: a shining saber. Chest 2008; 133 (1) 317-318 ; author reply 318
    CrossrefPubMedSuche in Google Scholar
  • 4 Kuo WT, Gould MK, Louie JD, Rosenberg JK, Sze DY, Hofmann LV. Catheter-directed therapy for the treatment of massive pulmonary embolism: systematic review and meta-analysis of modern techniques. J Vasc Interv Radiol 2009; 20 (11) 1431-1440
    CrossrefPubMedSuche in Google Scholar
  • 5 Zeni Jr PT, Blank BG, Peeler DW. Use of rheolytic thrombectomy in treatment of acute massive pulmonary embolism. J Vasc Interv Radiol 2003; 14 (12) 1511-1515
    CrossrefPubMedSuche in Google Scholar
  • 6 Uflacker R. Interventional therapy for pulmonary embolism. J Vasc Interv Radiol 2001; 12 (2) 147-164
    CrossrefPubMedSuche in Google Scholar
  • 7 De Gregorio MA, Gimeno MJ, Mainar A , et al. Mechanical and enzymatic thrombolysis for massive pulmonary embolism. J Vasc Interv Radiol 2002; 13 (2 Pt 1) 163-169
    CrossrefPubMedSuche in Google Scholar
  • 8 Barritt DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet 1960; 1 (7138) 1309-1312
    PubMedSuche in Google Scholar
  • 9 Hirsh J, Guyatt G, Albers GW, Harrington R, Schünemann HJ ; American College of Chest Physicians. Executive summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (6, Suppl) 71S-109S
    CrossrefPubMedSuche in Google Scholar
  • 10 Carson JL, Kelley MA, Duff A , et al. The clinical course of pulmonary embolism. N Engl J Med 1992; 326 (19) 1240-1245
    CrossrefPubMedSuche in Google Scholar
  • 11 Horlander KT, Mannino DM, Leeper KV. Pulmonary embolism mortality in the United States, 1979–1998: an analysis using multiple-cause mortality data. Arch Intern Med 2003; 163 (14) 1711-1717
    CrossrefPubMedSuche in Google Scholar
  • 12 Dismuke SE, Wagner EH. Pulmonary embolism as a cause of death. The changing mortality in hospitalized patients. JAMA 1986; 255 (15) 2039-2042
    CrossrefPubMedSuche in Google Scholar
  • 13 Dalen JE, Alpert JS. Natural history of pulmonary embolism. Prog Cardiovasc Dis 1975; 17 (4) 259-270
    CrossrefPubMedSuche in Google Scholar
  • 14 Krichavsky MZ, Rybicki FJ, Resnic FS. Catheter directed lysis and thrombectomy of submassive pulmonary embolism. Catheterization and cardiovascular interventions. Cathet Cardiac Intervent 2011; 77 (1) 144-147
    PubMedSuche in Google Scholar
  • 15 Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353 (9162) 1386-1389
    CrossrefPubMedSuche in Google Scholar
  • 16 Fiumara K, Kucher N, Fanikos J, Goldhaber SZ. Predictors of major hemorrhage following fibrinolysis for acute pulmonary embolism. Am J Cardiol 2006; 97 (1) 127-129
    CrossrefPubMedSuche in Google Scholar
  • 17 Wan S, Quinlan DJ, Agnelli G, Eikelboom JW. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation 2004; 110 (6) 744-749
    CrossrefPubMedSuche in Google Scholar
  • 18 Agnelli G, Becattini C, Kirschstein T. Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcome-based meta-analysis. Arch Intern Med 2002; 162 (22) 2537-2541
    CrossrefPubMedSuche in Google Scholar
  • 19 Thabut G, Thabut D, Myers RP , et al. Thrombolytic therapy of pulmonary embolism: a meta-analysis. J Am Coll Cardiol 2002; 40 (9) 1660-1667
    CrossrefPubMedSuche in Google Scholar
  • 20 Dong B, Jirong Y, Liu G, Wang Q, Wu T. Thrombolytic therapy for pulmonary embolism. Cochrane Database Syst Rev 2006; (2) CD004437
    PubMedSuche in Google Scholar
  • 21 Kucher N, Rossi E, De Rosa M, Goldhaber SZ. Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90.  mm Hg or higher. Arch Intern Med 2005; 165 (15) 1777-1781
    CrossrefPubMedSuche in Google Scholar
  • 22 Vedantham S, Grassi CJ, Ferral H , et al; Technology Assessment Committe of the Society of Interventional Radiology. Reporting standards for endovascular treatment of lower extremity deep vein thrombosis. J Vasc Interv Radiol 2006; 17 (3) 417-434
    CrossrefPubMedSuche in Google Scholar
  • 23 Verstraete M, Miller GA, Bounameaux H , et al. Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism. Circulation 1988; 77 (2) 353-360
    CrossrefPubMedSuche in Google Scholar
  • 24 Chamsuddin A, Nazzal L, Kang B , et al. Catheter-directed thrombolysis with the Endowave system in the treatment of acute massive pulmonary embolism: a retrospective multicenter case series. J Vasc Interv Radiol 2008; 19 (3) 372-376
    CrossrefPubMedSuche in Google Scholar
  • 25 Goldhaber SZ. Integration of catheter thrombectomy into our armamentarium to treat acute pulmonary embolism. Chest 1998; 114 (5) 1237-1238
    CrossrefPubMedSuche in Google Scholar
  • 26 Leacche M, Unic D, Goldhaber SZ , et al. Modern surgical treatment of massive pulmonary embolism: results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach. J Thorac Cardiovasc Surg 2005; 129 (5) 1018-1023
    CrossrefPubMedSuche in Google Scholar
  • 27 Jamieson SW, Auger WR, Fedullo PF , et al. Experience and results with 150 pulmonary thromboendarterectomy operations over a 29-month period. J Thorac Cardiovasc Surg 1993; 106 (1) 116-126 ; discussion 126–127
    PubMedSuche in Google Scholar
  • 28 Archibald CJ, Auger WR, Fedullo PF , et al. Long-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med 1999; 160 (2) 523-528
    CrossrefPubMedSuche in Google Scholar